Federal judge rejects Maine Rx data law
The law, scheduled to take effect Jan. 1, would prohibit “the transfer of truthful commercial information” and “violate the free speech guarantee,” US District Judge John Woodcock ruled Friday, according to the Associated Press.
Researchers IMS Health, Wolters Kluwer Health and Verispan had challenged the law.
“We believe that restrictions on the dissemination of information of crucial public interest are neither good healthcare policy nor consistent with our society's core beliefs in the free flow of information,” said Robert Steinfeld, IMS senior vice president and general counsel, in a statement about the ruling issued today.
Judge Woodcock noted that he relied heavily on an April 30 decision
by US District Judge Paul Barbadoro in
Maine's Prescription Restraint Law was one of several state measures designed to slow prescription drug costs for individual patients and state Medicaid plans.